Designing Growth Strategies is in our DNA

AI in Real-World Evidence Market Size, Share & Industry Analysis, By Component (Software/Platform and Services), By Deployment (Cloud-Based, On-Premise & Hybrid), By Technology (Machine Learning & Deep Learning, NLP/Generative AI), By Application (Cohort Discovery & Patient Stratification, Endpoint Extraction & NLP, Comparative Effectiveness & Outcomes Research, Safety Surveillance & Signal Detection, Regulatory & HTA Evidence Generation), By End User (Pharmaceutical & Biotechnology Companies, CROs/Real-world Data Vendors, Payers, Healthcare Providers), and Regional Forecast, 2026-2034

Last Updated :July 14, 2026 | Format:PDF | Report ID: 118102

 

Get a Quote

man icon
Mail icon
Captcha refresh
Get 30-60 Hours of FREE Customization on this Report
Company Mapping:

Additional company profiling and benchmarking

Competitive Intelligence:

Advanced competitive landscape assessment

Segment Broadening:

Expanded segment-level coverage

Use-Case Analysis:

Tailored application and end-user evaluation

Extended Study Period:

Extended forecast and historical period

Geographic Granularity:

More detailed regional and country-level insights

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 164